glp-1 medications approved for diabetes and weight loss 2025 Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care What are GLP-1s? | Mendinground

[4] [5] These symptoms result from delayed gastric emptying and direct effects on the gastrointestinal tract

Indeed GLP-1R agonists proved to be efficient for the treatment of type 2 diabetes mellitus 37 and studies indicate they could be used in other indications 26,43,44 such as obesity 45,46 , adverse cardiovascular events 25 , cognitive disorders 44 and non-alcoholic steatohepatitis (NASH) 47

Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement

& Lund, B